2013 Fiscal Year Final Research Report
Loss of ARID1A, a tumor suppressor gene, expression is related to the mechanism of chemoresistance in ovarian clear cell carcinoma
Project/Area Number |
23791844
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Obstetrics and gynecology
|
Research Institution | Shimane University |
Principal Investigator |
|
Project Period (FY) |
2011 – 2013
|
Keywords | 癌 / ゲノム / 癌抑制遺伝子 |
Research Abstract |
Recently, the ARID1A gene has been identified as a novel tumor suppressor in ovarian clear cell carcinoma (OCCC). The current study was designed to evaluate whether ARID1A was a prognostic factor for progression, survival, and chemoresistance in OCCC. Loss of ARID1A expression was identified in 9 (15.0%) of 60 OCCC samples. Loss of ARID1A correlated with shorter progression-free survival (PFS) (P<0.01) and tended to correlate with shorter overall survival in patients with OCCC treated with platinum-based chemotherapy. When data were stratified for the multivariate analysis, only the loss of ARID1A expression remained a significant predictor of reduced PFS (P=0.03). Tumors with loss of ARID1A were more likely to be chemoresistant than tumors with positive ARID1A (100.0 vs 40.0%, P=0.04). This study demonstrates that loss of ARID1A in OCCC is a negative prognostic factor in patients. Measurement of ARID1A expression may be a method to predict resistance in patients with OCCC.
|
Research Products
(21 results)
-
[Journal Article] ESR1 gene amplification in endometrial carcinomas : A clinicopathological analysis2013
Author(s)
Rahman MT, Nakayama K, Rahman M, Ishikawa M, Katagiri H, Katagiri A, Ishibashi T, Sato E, Iida K, Nakayama N, Ishikawa N, Miyazaki K
-
Journal Title
Anticancer Res.
Volume: 33
Pages: 3775-3781
-
[Journal Article] KRAS and MAPK1 gene amplification in type II ovarian carcinomas2013
Author(s)
Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Sato E, Iida K, Nakayama N, Ishikawa N, Miyazaki K
-
Journal Title
Int J Mol Sci.
Volume: 14
Pages: 13748-13762
-
-
[Journal Article] PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes2013
Author(s)
Rahman M, Nakayama K, Rahman MT, Nakayama N, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Otsuki Y, Nakayama S, Miyazaki K
-
Journal Title
Anticancer Res.
Volume: 33
Pages: 113-118
-
[Journal Article] Is ATP7B a predictive marker in patients with ovarian carcinoma treated with platinum-taxane combination chemotherapy?2013
Author(s)
Katagiri H, Nakayama K, Rahman MT, Rahman M, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Nakayama S, Otsuki Y, Miyazaki K
-
Journal Title
Int J Gynecol Cancer
Volume: 23
Pages: 60-64
-
-
[Journal Article] Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer2012
Author(s)
Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Nakayama S, Otsuki S, Miyazaki K
-
Journal Title
Am J Clin Pathol.
Volume: 138
Pages: 535-544
-
[Journal Article] NAC1, a BTB/POZ protein overexpressed in uterine sarcomas2012
Author(s)
Rahman MT, Nakayama K, Ishikawa M, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Iida K, Yamada T, Miyazaki K
-
Journal Title
Anticancer Res.
Volume: 32
Pages: 3841-3845
-
[Journal Article] Gene amplification of ZNF217 located at chr20q13.2 is associated with lymph node metastasis in ovarian clear cell carcinoma2012
Author(s)
Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Nakayama N, Otsuki Y, Nakayama S, Miyazaki K
-
Journal Title
Anticancer Res.
Volume: 32
Pages: 3091-3095
-
[Journal Article] Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma2012
Author(s)
R ahman M, Nakayama K, Rahman MT, Nakayama N, Ishikawa M, Katagiri A, Iida K, Nakayama S, Otsuki Y, Shih IeM, Miyazaki K
-
Journal Title
Hum Pathol
Volume: 43
Pages: 2197-2206
-
[Journal Article] Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas2012
Author(s)
Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Nakayama N, Otsuki Y, Nakayama S, Miyazaki K
-
Journal Title
Br J Cancer
Volume: 107
Pages: 300-307
-
[Journal Article] Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix2012
Author(s)
Katagiri A, Nakayama K, Rahman MT, Rahman M, Katagiri H, Ishikawa M, Ishibashi T, Iida K, Otsuki Y, Nakayama S, Miyazaki K
-
Journal Title
Int J Gynecol Cancer
Volume: 22
Pages: 208-212
-
[Journal Article] Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma2012
Author(s)
Rahman MT, Nakayama K, Rahman M, Nakayama N, Ishikawa M, Katagiri A, Iida K, Nakayama S, Otsuki Y, Shih IeM, Miyazaki K
-
Journal Title
Cancer
Volume: 118
Pages: 2846-2857
-
[Journal Article] Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma2012
Author(s)
Katagiri A, Nakayama K, Rahman MT, Rahman M, Katagiri H, Nakayama N Ishikawa M, Ishibashi T, Iida K, Otsuki Y, Nakayama S, Miyazaki K
-
Journal Title
Mod Pathol.
Volume: 25
Pages: 282-288
-
[Journal Article] Biological and clinical significance of NAC1 expression in cervical carcinomas : a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas2012
Author(s)
Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Iida K, Nakayama N, Otsuki Y, Kobayashi H, Nakayama S, Miyazaki K
-
Journal Title
Hum Pathol.
Volume: 43
Pages: 506-519
-
[Journal Article] EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target2011
Author(s)
Iida K, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Yeasmin S, Otsuki Y, Kobayashi H, Nakayama S, Miyazaki K
-
Journal Title
Br J Cancer
Volume: 105
Pages: 420-427
-
-
-
-
-